Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of mtDNA in SHR-mtF344 versus SHR conplastic strains on reduced OXPHOS enzyme levels, insulin resistance, cardiac hypertrophy, and systolic dysfunction

J. Houštěk, M. Vrbacký, K. Hejzlarová, V. Zídek, V. Landa, J. Šilhavý, M. Šimáková, P. Mlejnek, L. Kazdová, I. Mikšík, J. Neckář, F. Papoušek, F. Kolář, TW. Kurtz, M. Pravenec,

. 2014 ; 46 (18) : 671-8.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15023192

Common inbred strains of the laboratory rat can be divided into four major mitochondrial DNA (mtDNA) haplotype groups represented by the BN, F344, LEW, and SHR strains. In the current study, we investigated the metabolic and hemodynamic effects of the SHR vs. F344 mtDNA by comparing the SHR vs. SHR-mt(F344) conplastic strains that are genetically identical except for their mitochondrial genomes. Altogether 13 amino acid substitutions in protein coding genes, seven single nucleotide polymorphisms in tRNA genes, and 12 single nucleotide changes in rRNA genes were detected in F344 mtDNA compared with SHR mtDNA. Analysis of oxidative phosphorylation system (OXPHOS) in heart left ventricles (LV), muscle, and liver revealed reduced activity and content of several respiratory chain complexes in SHR-mt(F344) conplastic rats compared with the SHR strain. Lower function of OXPHOS in LV of conplastic rats was associated with significantly increased relative ventricular mass and reduced fractional shortening that was independent of blood pressure. In addition, conplastic rats exhibited reduced sensitivity of skeletal muscles to insulin action and impaired glucose tolerance. These results provide evidence that inherited alterations in mitochondrial genome, in the absence of variation in the nuclear genome and other confounding factors, predispose to insulin resistance, cardiac hypertrophy and systolic dysfunction.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023192
003      
CZ-PrNML
005      
20250618145818.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1152/physiolgenomics.00069.2014 $2 doi
035    __
$a (PubMed)25073601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Houštěk, Josef $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
245    10
$a Effects of mtDNA in SHR-mtF344 versus SHR conplastic strains on reduced OXPHOS enzyme levels, insulin resistance, cardiac hypertrophy, and systolic dysfunction / $c J. Houštěk, M. Vrbacký, K. Hejzlarová, V. Zídek, V. Landa, J. Šilhavý, M. Šimáková, P. Mlejnek, L. Kazdová, I. Mikšík, J. Neckář, F. Papoušek, F. Kolář, TW. Kurtz, M. Pravenec,
520    9_
$a Common inbred strains of the laboratory rat can be divided into four major mitochondrial DNA (mtDNA) haplotype groups represented by the BN, F344, LEW, and SHR strains. In the current study, we investigated the metabolic and hemodynamic effects of the SHR vs. F344 mtDNA by comparing the SHR vs. SHR-mt(F344) conplastic strains that are genetically identical except for their mitochondrial genomes. Altogether 13 amino acid substitutions in protein coding genes, seven single nucleotide polymorphisms in tRNA genes, and 12 single nucleotide changes in rRNA genes were detected in F344 mtDNA compared with SHR mtDNA. Analysis of oxidative phosphorylation system (OXPHOS) in heart left ventricles (LV), muscle, and liver revealed reduced activity and content of several respiratory chain complexes in SHR-mt(F344) conplastic rats compared with the SHR strain. Lower function of OXPHOS in LV of conplastic rats was associated with significantly increased relative ventricular mass and reduced fractional shortening that was independent of blood pressure. In addition, conplastic rats exhibited reduced sensitivity of skeletal muscles to insulin action and impaired glucose tolerance. These results provide evidence that inherited alterations in mitochondrial genome, in the absence of variation in the nuclear genome and other confounding factors, predispose to insulin resistance, cardiac hypertrophy and systolic dysfunction.
650    _2
$a adeninnukleotidy $x metabolismus $7 D000227
650    _2
$a zvířata $7 D000818
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a kardiomegalie $x genetika $x patofyziologie $7 D006332
650    _2
$a mitochondriální DNA $x genetika $7 D004272
650    _2
$a elektrokardiografie $7 D004562
650    _2
$a transport elektronů $x účinky léků $7 D004579
650    _2
$a genová dávka $7 D018628
650    _2
$a mitochondriální geny $7 D050259
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a glukózový toleranční test $7 D005951
650    _2
$a haplotypy $x genetika $7 D006239
650    _2
$a inzulin $x farmakologie $7 D007328
650    _2
$a inzulinová rezistence $x genetika $7 D007333
650    _2
$a metabolismus lipidů $x účinky léků $7 D050356
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a velikost orgánu $x účinky léků $7 D009929
650    12
$a oxidativní fosforylace $x účinky léků $7 D010085
650    _2
$a fenotyp $7 D010641
650    _2
$a RNA transferová $x genetika $7 D012343
650    _2
$a potkani inbrední F344 $7 D011916
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a sekvenční analýza DNA $7 D017422
650    12
$a systola $x účinky léků $7 D013599
650    _2
$a funkce levé komory srdeční $x účinky léků $7 D016277
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vrbacký, Marek $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Hejzlarová, Kateřina $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Zídek, Václav $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Landa, Vladimír $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Šilhavý, Jan $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Šimáková, Miroslava $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Mlejnek, Petr $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Kazdová, Ludmila, $d 1938-2025 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic; and. $7 xx0053119
700    1_
$a Mikšík, Ivan $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Neckář, Jan $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Papoušek, František $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Kolář, František $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic;
700    1_
$a Kurtz, Theodore W $u Department of Laboratory Medicine, University of California, San Francisco, California.
700    1_
$a Pravenec, Michal $u Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic; pravenec@biomed.cas.cz.
773    0_
$w MED00013840 $t Physiological genomics $x 1531-2267 $g Roč. 46, č. 18 (2014), s. 671-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25073601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20250618145809 $b ABA008
999    __
$a ok $b bmc $g 1083530 $s 906185
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 46 $c 18 $d 671-8 $i 1531-2267 $m Physiological genomics $n Physiol Genomics $x MED00013840
LZP    __
$a Pubmed-20150709

Find record

Citation metrics

Archiving options